Salud financiera de hoja de balance de Eris Lifesciences
Salud financiera controles de criterios 5/6
Eris Lifesciences tiene un patrimonio de accionistas total de ₹24.3B y una deuda total de ₹8.3B, lo que sitúa su ratio deuda-patrimonio en 34.2%. Sus activos y pasivos totales son ₹38.8B y ₹14.5B respectivamente. El BAIT de Eris Lifesciences es de ₹4.8B, por lo que su ratio de cobertura de intereses es de 8.3. Tiene efectivo e inversiones a corto plazo que ascienden a ₹1.9B.
Información clave
34.2%
Ratio deuda-patrimonio
₹8.30b
Deuda
| Ratio de cobertura de intereses | 8.3x |
| Efectivo | ₹1.91b |
| Patrimonio | ₹24.28b |
| Total pasivo | ₹14.48b |
| Activos totales | ₹38.75b |
Actualizaciones recientes sobre salud financiera
Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly
Dec 07
Does Eris Lifesciences (NSE:ERIS) Have A Healthy Balance Sheet?
Nov 20These 4 Measures Indicate That Eris Lifesciences (NSE:ERIS) Is Using Debt Safely
Jun 20Recent updates
An Intrinsic Calculation For Eris Lifesciences Limited (NSE:ERIS) Suggests It's 25% Undervalued
Mar 14Analyst Estimates: Here's What Brokers Think Of Eris Lifesciences Limited (NSE:ERIS) After Its Third-Quarter Report
Feb 15Earnings Tell The Story For Eris Lifesciences Limited (NSE:ERIS)
Dec 28Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly
Dec 07Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?
Nov 11Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?
Jul 20Does Eris Lifesciences (NSE:ERIS) Have A Healthy Balance Sheet?
Nov 20These 4 Measures Indicate That Eris Lifesciences (NSE:ERIS) Is Using Debt Safely
Jun 20A Look At The Fair Value Of Eris Lifesciences Limited (NSE:ERIS)
Feb 24Is Now The Time To Put Eris Lifesciences (NSE:ERIS) On Your Watchlist?
Dec 28Here's Why I Think Eris Lifesciences (NSE:ERIS) Might Deserve Your Attention Today
Sep 23If You Like EPS Growth Then Check Out Eris Lifesciences (NSE:ERIS) Before It's Too Late
May 26Eris Lifesciences Limited (NSE:ERIS) Shares Could Be 34% Above Their Intrinsic Value Estimate
Apr 17Eris Lifesciences Limited's (NSE:ERIS) Stock Has Fared Decently: Is the Market Following Strong Financials?
Mar 12Does Eris Lifesciences (NSE:ERIS) Deserve A Spot On Your Watchlist?
Feb 25Why Eris Lifesciences Limited (NSE:ERIS) Is A Dividend Rockstar
Feb 12Eris Lifesciences Limited (NSE:ERIS) Analysts Are Pretty Bullish On The Stock After Recent Results
Jan 30
Read This Before Buying Eris Lifesciences Limited (NSE:ERIS) Shares
Jan 17Our View On Eris Lifesciences' (NSE:ERIS) CEO Pay
Dec 30Is Eris Lifesciences Limited's (NSE:ERIS) Recent Performance Tethered To Its Attractive Financial Prospects?
Dec 10Eris Lifesciences (NSE:ERIS) Shareholders Booked A 25% Gain In The Last Year
Nov 23Is It Worth Buying Eris Lifesciences Limited (NSE:ERIS) For Its 1.1% Dividend Yield?
Oct 22How Does Eris Lifesciences' (NSE:ERIS) CEO Salary Compare to Peers?
Oct 01How Much Are Eris Lifesciences Limited (NSE:ERIS) Insiders Taking Off The Table?
Sep 14Investor Optimism Abounds Eris Lifesciences Limited (NSE:ERIS) But Growth Is Lacking
Aug 22Eris Lifesciences Limited (NSE:ERIS) Looks Interesting, And It's About To Pay A Dividend
Aug 08Should You Buy Eris Lifesciences Limited (NSE:ERIS) For Its Upcoming Dividend?
Aug 08Eris Lifesciences Limited's (NSE:ERIS) Risks Elevated At These Prices
Jul 28Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹9.6B) de ERIS superan a sus pasivos a corto plazo (₹5.0B).
Pasivo a largo plazo: Los activos a corto plazo de ERIS (₹9.6B) superan a sus pasivos a largo plazo (₹9.5B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: El ratio deuda neta-patrimonio (26.3%) de ERIS se considera satisfactorio.
Reducción de la deuda: El ratio deuda-patrimonio de ERIS ha crecido de 26.5% a 34.2% en los últimos 5 años.
Cobertura de la deuda: La deuda de ERIS está bien cubierta por el flujo de caja operativo (53.6%).
Cobertura de intereses: Los pagos de intereses de la deuda de ERIS están bien cubiertos por el BAIT (8.3x cobertura).